Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Adolfsson

Showing results (81-90 of 168) with videos related to

Pageof 17
Sort By:
Acta Oncologica (Stockholm, Sweden)|October 31, 2018
Anti-androgen monotherapy versus gonadotropin-releasing hormone agonists in men with advanced, non-metastatic prostate cancer: a register-based, observational studyFrederik Birkebæk Thomsen, Cecilia Bosco, Hans Garmo, et al.
European Urology|March 6, 2012
Concordance of tumor differentiation among brothers with prostate cancerK Fredrik Jansson, Olof Akre, Hans Garmo, et al.
European Urology|July 31, 2012
A population-based assessment of germline HOXB13 G84E mutation and prostate cancer riskRobert Karlsson, Markus Aly, Mark Clements, et al.
The New England Journal of Medicine|September 13, 2002
Quality of life after radical prostatectomy or watchful waitingGunnar Steineck, Fred Helgesen, Jan Adolfsson, et al.
BJU International|April 19, 2017
Association between type 2 diabetes, curative treatment and survival in men with intermediate- and high-risk localized prostate cancerDanielle Crawley, Hans Garmo, Sarah Rudman, et al.
European Urology|February 8, 2011
Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort studyMarkus Aly, Fredrik Wiklund, Jianfeng Xu, et al.
European Urology|April 30, 2019
The Impact of Design and Performance in Prostate-Specific Antigen Screening: Differences Between ERSPC CentersEveline A M Heijnsdijk, Jan Adolfsson, Anssi Auvinen, et al.
Scandinavian Journal of Urology|December 18, 2019
Long-term adherence to GnRH agonists in men with prostate cancer. A nation-wide population-based study in prostate cancer data base SwedenGincy George, Hans Garmo, Sarah Rudman, et al.
Scandinavian Journal of Urology and Nephrology|November 20, 2009
Nationwide population-based study on 30-day mortality after radical prostatectomy in SwedenSigrid Carlsson, Jan Adolfsson, Ola Bratt, et al.
International Journal of Cancer|March 10, 2011
Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe SwedenDavid Robinson, Hans Garmo, Bertil Lindahl, et al.
Pageof 17

Showing results (81-90 of 168) with videos related to

Sort By:
Pageof 17
Acta Oncologica (Stockholm, Sweden)|October 31, 2018
Anti-androgen monotherapy versus gonadotropin-releasing hormone agonists in men with advanced, non-metastatic prostate cancer: a register-based, observational studyFrederik Birkebæk Thomsen, Cecilia Bosco, Hans Garmo, et al.
European Urology|March 6, 2012
Concordance of tumor differentiation among brothers with prostate cancerK Fredrik Jansson, Olof Akre, Hans Garmo, et al.
European Urology|July 31, 2012
A population-based assessment of germline HOXB13 G84E mutation and prostate cancer riskRobert Karlsson, Markus Aly, Mark Clements, et al.
The New England Journal of Medicine|September 13, 2002
Quality of life after radical prostatectomy or watchful waitingGunnar Steineck, Fred Helgesen, Jan Adolfsson, et al.
BJU International|April 19, 2017
Association between type 2 diabetes, curative treatment and survival in men with intermediate- and high-risk localized prostate cancerDanielle Crawley, Hans Garmo, Sarah Rudman, et al.
European Urology|February 8, 2011
Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort studyMarkus Aly, Fredrik Wiklund, Jianfeng Xu, et al.
European Urology|April 30, 2019
The Impact of Design and Performance in Prostate-Specific Antigen Screening: Differences Between ERSPC CentersEveline A M Heijnsdijk, Jan Adolfsson, Anssi Auvinen, et al.
Scandinavian Journal of Urology|December 18, 2019
Long-term adherence to GnRH agonists in men with prostate cancer. A nation-wide population-based study in prostate cancer data base SwedenGincy George, Hans Garmo, Sarah Rudman, et al.
Scandinavian Journal of Urology and Nephrology|November 20, 2009
Nationwide population-based study on 30-day mortality after radical prostatectomy in SwedenSigrid Carlsson, Jan Adolfsson, Ola Bratt, et al.
International Journal of Cancer|March 10, 2011
Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe SwedenDavid Robinson, Hans Garmo, Bertil Lindahl, et al.
Pageof 17